
Demo catalogue
KEIFEI PHARMA – LIGANBOL (LIGANDROL, LGD 4033) 10mg/tab, 50 tablets
£50.00

£60.00
Testolonebol (RAD-140) is an investigational selective androgen receptor modulator (SARM) , originally developed as a potential future substitute for exogenous Testosterone replacement therapy (TRT) .
| Pharmaceutical name | Testolonebol |
|---|---|
| Chemical name | Testolone (RAD-140) |
| Molecular formula | C20H16ClN5O2 |
| Molecular weight | 393.83 g/mol |
Each tablet contains 10mg of RAD-140.
Tablets are metallic blue, film-coated, round and concave, with a KF imprint on one side.
Sealed bottle of 50 tablets with QR authentication label.
5 strips × 10 tablets (50 total) per box, with QR authentication printed on the box.
Testolonebol (RAD-140) is an investigational selective androgen receptor modulator (SARM), originally developed as a potential future substitute for exogenous Testosterone replacement therapy (TRT). Its mechanism selectively targets androgen receptors in muscle and bone tissue, aiming to provide anabolic benefits with fewer androgenic side effects.
Treatment of muscle wasting conditions.
Support in osteoporosis and skeletal wasting disorders.
Investigated for use in breast cancer-related cachexia.
Investigated as an alternative to traditional TRT (Testosterone Replacement Therapy).
RAD-140 is currently under development by Radius Health, Inc. (RDUS). While showing promising anabolic properties, it remains an investigational compound not yet approved for medical use.
2-Chloro-4-({(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl}amino)-3-methylbenzonitrile
Important: RAD-140 is classified as a research compound in most regions. It should only be used under appropriate professional guidance and in compliance with local laws and anti-doping regulations.